MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 48 filers reported holding MERSANA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $712,000 | -16.0% | 52,415 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $848,000 | +10500.0% | 52,415 | +16027.7% | 0.00% | – |
| Q2 2020 | $8,000 | -99.4% | 325 | -99.9% | 0.00% | -100.0% |
| Q4 2018 | $1,449,000 | -59.2% | 355,055 | 0.0% | 0.00% | -40.0% |
| Q3 2018 | $3,551,000 | -44.0% | 355,055 | 0.0% | 0.01% | -50.0% |
| Q2 2018 | $6,341,000 | -15.1% | 355,055 | -25.0% | 0.01% | -52.4% |
| Q1 2018 | $7,466,000 | -4.0% | 473,407 | 0.0% | 0.02% | -4.5% |
| Q4 2017 | $7,778,000 | – | 473,407 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |